4th Quarter - Report — NATIONAL PATIENT ADVOCATE FOUNDATION for NATIONAL PATIENT ADVOCATE FOUNDATION (2008)

Firm

NATIONAL PATIENT ADVOCATE FOUNDATION

Client

NATIONAL PATIENT ADVOCATE FOUNDATION

Income

—

Expenses

$64,193

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement, social security disability

Lobbyist	Covered position, as disclosed
NANCY DAVENPORT-ENNIS	—
GRAYSON FOWLER	—
AMY WOTRING	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Natl Institutes of Health (NIH)

Health Issues HCR

Pre-existing condition legislation, prescription drug reimbursement, health information technology, e-prescribing, medical imaging, FDA regulation of tobacco, patient safety and quality improvement

Lobbyist	Covered position, as disclosed
NANCY DAVENPORT-ENNIS	—
GRAYSON FOWLER	—
AMY WOTRING	—

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Labor HHS Appropriations: appropriations levels for NIH, NCI, CDC and AHRQ Agriculture Appropriations: appropriations level for FDA

Lobbyist	Covered position, as disclosed
NANCY DAVENPORT-ENNIS	—
GRAYSON FOWLER	—
AMY WOTRING	—

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.